Antimicrobial stewardship in pediatric population

Pramod Jog

D.Y. Patil Medical College, India

Received Date: 2022-01-07 | Accepted Date: 2022-01-14 | Published Date: 2022-01-21
Visit for more related articles at Pediatric Infectious Diseases: Open Access

Abstract

Antimicrobial resistance (AMR) is a universal threat. It is one of the major contributing factors for increased morbidity, mortality and health care cost in hospitalized patients including children. There have been various factors behind the rise of AMR in India. The following aspects are discussed: antibiotic resistance including associated scenario, goals and benefits of implementing ASP, why the emerging need for ASP? Including the need of ASP for pediatric age group, existing efforts in to reduce AMR, problems associated with implementation in, what can be done to reduce the AMR? Antimicrobial resistance (AMR) is the ability of a microbe to resist the effects of medication that once could successfully eradicate the microbe. Resistant microbes are more difficult to treat, requiring alternative medications or higher doses of antimicrobials. Antimicrobial resistance is a universal threat. It is one of the major contributing factors for increased morbidity, mortality and health care cost in hospitalized patients including children. To reduce antimicrobial resistance the antimicrobial stewardship programme (ASP) came into existence. An Antimicrobial stewardship programme is defined (by WHO) as the “optimal selection, dosage, and duration of antimicrobial treatment that results in the best clinical outcome for the treatment or prevention of infection, with minimal toxicity to the patient and minimal impact on subsequent resistance".

open access journals, open access scientific research publisher, open access publisher
Select your language of interest to view the total content in your interested language

Viewing options

Flyer image

Share This Article